iShares Genomics Immunology and Healthcare ETF
IDNA
79 hedge funds and large institutions have $85.8M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 5 closing their positions.
320% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 5
220% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 10
31% more capital invested
Capital invested by funds: $65.5M → $85.8M (+$20.4M)
25% more funds holding
Funds holding: 63 → 79 (+16)
7.25% more ownership
Funds ownership: 19.58% → 26.83% (+7.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$8.9M |
| 2 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$4.77M |
| 3 |
SHJ
Sharkey, Howes & Javer
Denver,
Colorado
|
+$3.17M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.74M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.23M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
-$1.2M |
| 3 |
AIC
Archer Investment Corporation
Carmel,
Indiana
|
-$293K |
| 4 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
-$279K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$262K |
IDNA Hedge Fund Activity: Q1 2021 in Review
79 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q1 2021, worth a combined $85.8M — up 31% from $65.5M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new IDNA positions and 5 closed out — a net gain of 16 holders — while 32 added to existing stakes and 10 trimmed.
The largest buyer was Jane Street, adding an estimated $8.9M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.23M sold.
- 79 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q1 2021, up from 63 in Q4 2020.
- Funds reported $85.8M of iShares Genomics Immunology and Healthcare ETF stock for Q1 2021, up 31% quarter-over-quarter.
- 21 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q1 2021 and 5 closed out, a net change of +16 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q1 2021 was Jane Street, an estimated $8.9M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q1 2021 was Susquehanna International Group, an estimated $1.23M sold.
Based on aggregated 13F filings for Q1 2021.